Argitalpenak (50) María Inmaculada Colina Lorda argitalpenak

2024

  1. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  2. Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome

    Clinica Chimica Acta, Vol. 557

  3. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

2023

  1. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2021

  1. Association of sdf1 and mmp12 with atherosclerosis and inflammation: Clinical and experimental study

    Life, Vol. 11, Núm. 5

2020

  1. Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  2. Exploring the association between emphysema phenotypes and low bone mineral density in smokers with and without copd

    International Journal of COPD, Vol. 15, pp. 1823-1829

  3. Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 1, pp. 21-37

  4. Unravelling gender-specific factors that link obesity to albuminuria

    European Journal of Clinical Investigation, Vol. 50, Núm. 11

2019

  1. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation

    Nutrients, Vol. 11, Núm. 2

  2. Analysis of monocitary subpopulations in relation to cardiovascular risk factors

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  3. Análisis de subpoblaciones monocitarias en relación con los factores de riesgo cardiovascular

    Clínica e investigación en arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  4. Comparison of correlations of equation-derived body fat percentage and body mass index with carotid intima-media thickness

    Acta Diabetologica, Vol. 56, Núm. 3, pp. 373-375

  5. Trabecular bone score and bone remodelling markers identify perimenopausal women at high risk of bone loss

    Clinical Endocrinology, Vol. 91, Núm. 3, pp. 391-399

  6. Trabecular bone score in active or former smokers with and without COPD

    PLoS ONE, Vol. 14, Núm. 2

2018

  1. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589

2017

  1. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome

    Scientific Reports, Vol. 7, Núm. 1

  2. Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients

    Respiratory Research, Vol. 18, Núm. 1

2014

  1. Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification

    Clinical Biochemistry, Vol. 47, Núm. 18, pp. 272-278

2013

  1. Epicardial Adipose Tissue in Patients with Chronic Obstructive Pulmonary Disease

    PLoS ONE, Vol. 8, Núm. 6